Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Apr 2, 2018 · 10-K · 92 days after period end · 0001493152-18-004423
derived · Computed from the longer spans the company filed.
| Metric | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$2.77M | -$4.70M | -$7.98M | -$1.06M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Apr 2, 2018 · 92 d after period end
